Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma

10.1007/s00262-022-03158-9

Saved in:

Bibliographic Details
Main Authors:	Lim, Chwee Ming, Liou, Anthony, Poon, Michelle, Koh, Liang Piu, Tan, Lip Kun, Loh, Kwok Seng, Petersson, Bengt Fredrik, Ting, Eric, Campana, Dario, Goh, Boon Cher, Shimasaki, Noriko
Other Authors:	DIAGNOSTIC RADIOLOGY
Format:	Article
Language:	English
Published:	SPRINGER 2022
Subjects:	NK cell therapy Nasopharyngeal carcinoma EGFR Cetuximab Clinical trial
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/228658
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-228658
record_format	dspace
spelling	sg-nus-scholar.10635-2286582024-11-14T22:05:29Z Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma Lim, Chwee Ming Liou, Anthony Poon, Michelle Koh, Liang Piu Tan, Lip Kun Loh, Kwok Seng Petersson, Bengt Fredrik Ting, Eric Campana, Dario Goh, Boon Cher Shimasaki, Noriko DIAGNOSTIC RADIOLOGY MEDICINE DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) OTOLARYNGOLOGY BIOLOGICAL SCIENCES PAEDIATRICS PATHOLOGY Assoc Prof Liang Piu Koh NK cell therapy Nasopharyngeal carcinoma EGFR Cetuximab Clinical trial 10.1007/s00262-022-03158-9 CANCER IMMUNOLOGY IMMUNOTHERAPY 2022-07-15T07:00:45Z 2022-07-15T07:00:45Z 2022-01-30 2022-07-14T03:34:28Z Article Lim, Chwee Ming, Liou, Anthony, Poon, Michelle, Koh, Liang Piu, Tan, Lip Kun, Loh, Kwok Seng, Petersson, Bengt Fredrik, Ting, Eric, Campana, Dario, Goh, Boon Cher, Shimasaki, Noriko (2022-01-30). Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma. CANCER IMMUNOLOGY IMMUNOTHERAPY. ScholarBank@NUS Repository. https://doi.org/10.1007/s00262-022-03158-9 0340-7004 1432-0851 https://scholarbank.nus.edu.sg/handle/10635/228658 en SPRINGER Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	NK cell therapy Nasopharyngeal carcinoma EGFR Cetuximab Clinical trial
spellingShingle	NK cell therapy Nasopharyngeal carcinoma EGFR Cetuximab Clinical trial Lim, Chwee Ming Liou, Anthony Poon, Michelle Koh, Liang Piu Tan, Lip Kun Loh, Kwok Seng Petersson, Bengt Fredrik Ting, Eric Campana, Dario Goh, Boon Cher Shimasaki, Noriko Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
description	10.1007/s00262-022-03158-9
author2	DIAGNOSTIC RADIOLOGY
author_facet	DIAGNOSTIC RADIOLOGY Lim, Chwee Ming Liou, Anthony Poon, Michelle Koh, Liang Piu Tan, Lip Kun Loh, Kwok Seng Petersson, Bengt Fredrik Ting, Eric Campana, Dario Goh, Boon Cher Shimasaki, Noriko
format	Article
author	Lim, Chwee Ming Liou, Anthony Poon, Michelle Koh, Liang Piu Tan, Lip Kun Loh, Kwok Seng Petersson, Bengt Fredrik Ting, Eric Campana, Dario Goh, Boon Cher Shimasaki, Noriko
author_sort	Lim, Chwee Ming
title	Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
title_short	Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
title_full	Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
title_fullStr	Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
title_full_unstemmed	Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
title_sort	phase i study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
publisher	SPRINGER
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/228658
_version_	1821223300593876992

Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma

Similar Items